Wall Street analyst estimates for UFP Technologies, Inc. (UFPT): consensus price target and buy/hold/sell recommendations.
UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surg...
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (−2 sell to +2 buy) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-03 | $2.49 | ||
| 2026-08-03 | $2.69 | $2.31 | +16.5% |
| 2026-05-04 | $2.27 | $2.18 | +4.1% |
| 2026-02-24 | $2.44 | $2.26 | +8.0% |
| 2025-11-03 | $2.39 | $2.22 | +7.7% |
| 2025-08-04 | $2.50 | $2.29 | +9.2% |
| 2025-05-06 | $2.47 | $2.05 | +20.5% |
| 2025-02-25 | $2.46 | $1.98 | +24.2% |
Valuation Ratios
| P/E Ratio | 30.69 |
| Price / Book | 4.76 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $146.1M | $147.8M | $190.5M | $198.4M | $179.4M | $206.3M | $353.8M | $400.1M | $504.4M | $602.8M |
| Cost of Revenue | $111.5M | $112.4M | $142.1M | $144.4M | $134.7M | $155.2M | $263.5M | $287.8M | $357.7M | $432.4M |
| Gross Profit | $34.6M | $35.5M | $48.3M | $54.0M | $44.7M | $51.1M | $90.3M | $112.2M | $146.7M | $170.4M |
| Research & Development | $1.3M | $1.1M | $10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $24.1M | $23.8M | $27.8M | $29.3M | $27.5M | $29.5M | $45.8M | $50.9M | $62.2M | $77.4M |
| Operating Expenses | $24.1M | $23.8M | $27.8M | $29.3M | $28.0M | $29.9M | $34.9M | $54.6M | $65.8M | $78.1M |
| Operating Income | $12.2M | $11.7M | $19.6M | $24.7M | $16.7M | $21.2M | $55.4M | $57.7M | $80.9M | $92.3M |
| EBITDA | $18.0M | $17.4M | $28.5M | $32.5M | $24.6M | $29.7M | $67.4M | $69.0M | $95.8M | $111.5M |
| Interest Expense | $69,000 | $50,000 | $1.3M | $674,000 | $83,000 | $39,000 | $2.8M | $3.6M | $8.1M | $9.8M |
| Pre-tax Income | $12.3M | $11.9M | $18.4M | $23.6M | $16.3M | $21.2M | $52.7M | $53.9M | $73.0M | $82.5M |
| Income Tax | $4.3M | $2.6M | $4.1M | $3.9M | $2.9M | $5.3M | $10.9M | $9.0M | $14.0M | $14.2M |
| Net Income | $8.0M | $9.2M | $14.3M | $19.8M | $13.4M | $15.9M | $41.8M | $44.9M | $59.0M | $68.3M |
| EPS | $1.11 | $1.27 | $1.95 | $2.66 | $1.79 | $2.11 | $5.52 | $5.89 | $7.69 | $8.87 |
| EPS (Diluted) | $1.10 | $1.26 | $1.93 | $2.63 | $1.77 | $2.09 | $5.45 | $5.83 | $7.58 | $8.77 |
| Shares Outstanding (Diluted) | 7.3 M | 7.3 M | 7.4 M | 7.5 M | 7.6 M | 7.6 M | 7.7 M | 7.7 M | 7.8 M | 7.8 M |
Price
| Price | $284.50 (closing price, October 30, 2026) |
| Market Cap | $2.2B |
| Exchange | NASDAQ |
| Country | US |
Related companies: GEHC · MDT · ABT · 0Y6X.L · SYK · 0R2S.L · 0HOY.L · BSX
Explore sector: Healthcare · Medical - Devices
More sections of UFPT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks